Maybe it’s because of the new billing codes for cardiac telemetry devices, but the newscycle is brimming with announcements from wireless implantable cardiac monitoring devices this week. We just wrote about Medtronic’s Reveal XT, now the FDA announced approval for Transoma Medical’s Sleuth AT, which is also an implantable wireless cardiac monitor that communicates with a personal device the patient carriers in a pocket or purse or with a home base station that can notify the patient’s physician if abnormal activity is detected.
The Sleuth AT Cardiac Monitoring System includes: Implantable Loop Recorder (ILR), the Personal Diagnostic Manager (PDM), the Base Station and a 24/7 Monitoring Center operated by Medicomp.
Users of the system who experience symptoms, like lightheadedness, can press a button on their personal device monitor that tells the system to capture an ECG at that moment. It also automatically captures ECGs when patterns stray above or below physician established parameters. The system can also be programmed to capture ECGs every 4 hours, 15 minutes or 7.5 minutes.
For more, check out the company’s press release here.